Investor Updates

Company Overview

NightHawk Biosciences is a fully integrated biopharmaceutical company specializing in the end-to-end development and commercialization of therapies that arm the immune system against a wide range of diseases including cancer and infectious disease. Our ecosystem is driven by the discovery efforts of SkunkWorx Bio, Inc, the preclinical and clinical development expertise of Heat Biologics, Inc, Pelican Therapeutics, Inc, and Elusys Therapeutics, Inc., and our in-house contract research and development biomanufacturing organization (CDMO) Scorpion Biologics, Inc. These unique capabilities decrease our reliance on external vendors and reinforce our goal of increasing the efficiency of drug development to accelerate the delivery of novel immune activating therapies.